SUBSCRIBE TO TMCnet
TMCnet - World's Largest Communications and Technology Community

TMCNet:  Cryoablation Shows Promise as a Non-Surgical Alternative Treatment for Early Stage Breast Cancer

[April 30, 2014]

Cryoablation Shows Promise as a Non-Surgical Alternative Treatment for Early Stage Breast Cancer

LAS VEGAS --(Business Wire)--

Non-surgical cryoablation of breast cancer - destruction of diseased tissue by exposure to freezing temperatures - shows promise as an alternative to surgery for selected women with early stage invasive ductal cancer (IDC (News - Alert)), according to a new phase II clinical trial presented this week at the American Society of Breast Surgeons (ASBrS) Annual Meeting. The study found that 100% of patients' tumors less than 1 cm in size treated with cryoablation had no residual invasive cancer on pathological examination of the targeted lesion. The success rate for cancers of any size was 80.5%. For 69% of patients, cryoablation was successful when defined as no residual IDC or ductal cancer in situ (DCIS), a precursor to cancer.

"With cryoablation, a woman need not even enter the operating room for treatment, and he procedure can be as brief as 20 minutes," comments Rache Simmons, MD, Chief of Breast Surgery at New York Presbyterian/Weill Cornell Medical Center and lead author of the study. "Compared to surgery, cryoablation is far less invasive and provides better cosmetic results, shorter procedure time and faster recovery."


The technique is well-established for treatment of non-cancerous breast fibroadenomas and has been routinely used for other cancers for some time. Earlier studies also suggested that cryoablation is an effective non-surgical treatment for breast cancer in a certain early stage patients . . .Cont.

https://www.breastsurgeons.org/new_layout/annual_meeting2014/news_releases.php

LINK TO FULL PRESS KIT FROM AMERICAN SOCIETY OF BREAST SURGEONS ANNUAL MEETING PRESS CONFERENCE, WITH FULL RELEASE AND ADDITIONAL PRESS RELEASES ON (News - Alert):

  • Lymph Node Radiotherapy Emerges as the Preferred Treatment for Breast Cancer Patients with Positive Nodes
  • Mortality and Complication Rates with Metastatic Breast Cancer Surgery
  • Increasing Prophylactic Mastectomy Rates


[ Back To Technology News's Homepage ]

OTHER NEWS PROVIDERS







Technology Marketing Corporation

800 Connecticut Ave, 1st Floor East, Norwalk, CT 06854 USA
Ph: 800-243-6002, 203-852-6800
Fx: 203-866-3326

General comments: tmc@tmcnet.com.
Comments about this site: webmaster@tmcnet.com.

STAY CURRENT YOUR WAY

© 2014 Technology Marketing Corporation. All rights reserved | Privacy Policy